Support

Ongoing research projects

2020–2022
Role of the cytoplasmic domain of the NMDA receptor for its biogenesis, function, and pharmacology: Focus on disease-associated mutations
Grant Agency of the Czech Republic; project № 20-17945S 

2019–2021
Molecular mechanisms of allosteric modulation of muscarinic acetylcholine receptors by neurosteroids and cholesterol
Grant Agency of the Czech Republic; project № 19-05318S

2019–2020
PerMed: Personalized Medicine – Diagnostics and Therapy
National Centres of Competence 1, Technology Agency of the Czech Republic (TN01000013)

2018–2022
PharmaBrain
Ministry of Education, Youth and Sports, European Structural and Investment Funds
Operational Programme Research, Developmenta and Education – project № CZ.02.1.01/0.0/0.0/16_025/0007444

Completed research projects

2018–2020
Identification of new molecules that are able to interact with allosteric binding sites on purinergic P2X receptors
Grant Agency of the Czech Republic; project № 18-05413S

2017–2019
Molecular, cellular, and behavioral effects of NMDA receptor-modulating steroids
Grant Agency of the Czech Republic; project № 17-02300S

2012–2019
Center for Development of Original Drugs
Technology Agency of the Czech Republic (TE01020028)

2015–2019
Genetic and functional studies of NMDA receptors targeted on the prospective diagnosis and treatment of schizophrenia
Applied Health Research Support Program for 2015-2022, Czech Health Research Council; project № NV 15-29370A